José Alberto López-Domínguez

5PUBLICATIONS
40CO-AUTHORS
ChemotherapyPredictive and prognostic markersInnate immunityMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez

|Oct 27, 2022
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity.

Ines Marin, Olga Boix, Andrea Garcia-Garijo

|Dec 11, 2020
Author Correction: Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages.

Anthony J Covarrubias, Abhijit Kale, Rosalba Perrone

|Nov 17, 2020
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages.

Anthony J Covarrubias, Abhijit Kale, Rosalba Perrone

Pageof 1